These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9123572)

  • 1. Efficiency of fucans in protecting porcine endothelial cells against complement activation and lysis by human serum.
    Charreau B; Blondin C; Boisson-Vidal C; Soulillou JP; Anegon I
    Transplant Proc; 1997; 29(1-2):889-90. PubMed ID: 9123572
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.
    Laumonier T; Walpen AJ; Maurus CF; Mohacsi PJ; Matozan KM; Korchagina EY; Bovin NV; Vanhove B; Seebach JD; Rieben R
    Transplantation; 2003 Sep; 76(5):838-43. PubMed ID: 14501864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
    Dalmasso AP; Platt JL
    Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidant stress increases susceptibility of porcine endothelial cells to injury by xenoreactive antibody and complement.
    Magee JC; Platt JL; Oldham KT; Guice KS
    Transplant Proc; 1994 Jun; 26(3):1170. PubMed ID: 8029874
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelial cells from human decay acceleration factor transgenic pigs are protected against complement mediated tissue factor expression in vitro.
    Tucker AW; Carrington CA; Richards AC; Robson SC; White DJ
    Transplant Proc; 1997; 29(1-2):888. PubMed ID: 9123571
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of C1 inhibitor plus heparin in prevention of complement-mediated activation of endothelial cells in a model of xenograft hyperacute rejection.
    Dalmasso AP; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1246-7. PubMed ID: 8029898
    [No Abstract]   [Full Text] [Related]  

  • 7. alphaGAL ligation with a lectin induces activation and resistance to the proinflammatory effects of human complement on porcine endothelium.
    Grehan JF; Kulick DM; Guzman-Paz M; Bolman RM; Dalmasso AP
    Transplant Proc; 2000 Aug; 32(5):975. PubMed ID: 10936307
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical basis for induction of resistance to human complement in porcine endothelial cells by alphaGAL ligation.
    Dalmasso AP; Benson BA; Schroeder AA; Abrahamsen MS
    Transplant Proc; 2000 Aug; 32(5):974. PubMed ID: 10936306
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
    Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated.
    Sølvik UØ; Haraldsen G; Fiane AE; Boretti E; Lambris JD; Fung M; Thorsby E; Mollnes TE
    Transplantation; 2001 Dec; 72(12):1967-73. PubMed ID: 11773897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
    Cable DG; Hisamochi K; Schaff HV
    Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation.
    Saethre M; Lea T; Borgen MS; Fiane AE; Michaelsen TE; Thorsby E; Haraldsen G; Mollnes TE
    Xenotransplantation; 2006 May; 13(3):215-23. PubMed ID: 16756564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaction of complement with endothelial cells in a model of xenotransplantation.
    Dalmasso AP; Platt JL; Bach FH
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):31-5. PubMed ID: 1718641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.
    Baumann BC; Forte P; Hawley RJ; Rieben R; Schneider MK; Seebach JD
    J Immunol; 2004 May; 172(10):6460-7. PubMed ID: 15128838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
    Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
    Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of statins in xenotransplantation.
    Ezzelarab M; Cooper DK
    Xenotransplantation; 2007 Mar; 14(2):100-3. PubMed ID: 17381683
    [No Abstract]   [Full Text] [Related]  

  • 19. A newly established porcine aortic endothelial cell line: characterization and application to the study of human-to-swine graft rejection.
    Malassagne B; Taboit F; Conti F; Batteux F; Atia N; Chéreau C; Conjeaud H; Théron MC; Attal J; Braet F; Houdebine LM; Calmus Y; Houssin D; Weill B
    Exp Cell Res; 1998 Jan; 238(1):90-100. PubMed ID: 9457060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.